Gene · 6876
Papers4,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance. | J Extracell Vesicles | 2026 | 41581122 | PubTator, text mining | PubMed |
| Protocol for differentiation of vascular smooth muscle cells from human iPSCs and their application in CRISPRa-mediated gene regulation. | STAR Protoc | 2026 | 41575845 | PubTator, text mining | PubMed |
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| ALK-negative inflammatory myofibroblastic tumor with an undetermined differentiation direction: A case report and review of the literature. | Medicine (Baltimore) | 2026 | 41560086 | PubTator, text mining | PubMed |
| Identification of a novel real-time PCR reference gene panel for EA.hy926 endothelial cells in different growth States and with DHA treatment. | Sci Rep | 2026 | 41559137 | PubTator, text mining | PubMed |
| IGF2BP3-dependent glutamine/BCAA metabolic rewiring rejuvenates aged human adipose-derived stem cells for enhanced tissue regeneration. | Cell Discov | 2026 | 41559031 | PubTator, text mining | PubMed |
| Notch signaling activation reduces vesicular endocytosis in human pluripotent stem cell-derived CNS-like endothelial cells. | Fluids Barriers CNS | 2026 | 41546116 | PubTator, text mining | PubMed |
| Long non-coding RNA lncAPAT promotes atherosclerotic plaque instability by targeting ribosomal protein L22. | Clin Transl Med | 2026 | 41527512 | PubTator, text mining | PubMed |
| A standardized approach for the isolation of vascular smooth muscle cells from carotid atherosclerotic plaques. | Sci Rep | 2026 | 41519833 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of nonalcoholic fatty liver disease complicated by atherosclerosis via bioinformatics. | Medicine (Baltimore) | 2026 | 41517672 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Peptidase 8 Mediates Angiotensin-II-Induced Smooth Muscle Cell Phenotypic Transformation during Hypertension via Regulating LRRC8A. | Am J Hypertens | 2026 | 41499430 | PubTator, text mining | PubMed |
| TRAF6 mediates vascular remodeling via endoplasmic reticulum stress-mitophagy in hypoxic pulmonary hypertension. | Free Radic Biol Med | 2026 | 41429276 | PubTator, text mining | PubMed |
| SREBF1 maintains the contractile phenotype of vascular smooth muscle cells via PPARγ signalling. | Prostaglandins Other Lipid Mediat | 2026 | 41412334 | PubTator, text mining | PubMed |
| Vitamin D attenuates PCSK9-driven phenotypic switch of vascular smooth muscle cells and neointimal hyperplasia via SIRT6 activation. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41391502 | PubTator, text mining | PubMed |
| Identification of cancer-associated fibroblasts and analysis of the association of origin with endothelial-to-mesenchymal transition in hepatocellular carcinoma. | Scand J Gastroenterol | 2026 | 41320635 | PubTator, text mining | PubMed |
| Development of a Stereolithography 3D Printing-Based Micropatterning Method to Study Endothelial-to-Mesenchymal Transition Mechanobiology. | Ann Biomed Eng | 2026 | 41296227 | PubTator, text mining | PubMed |
| ATF4 transcriptional regulation of OMD and STC2 drives vascular calcification progression via the PI3K/AKT pathway. | Pathol Res Pract | 2026 | 41274065 | PubTator, text mining | PubMed |
| Differential gene expression in peripheral vascular smooth muscle cells of patients with peripheral artery disease. | Clin Exp Nephrol | 2026 | 41123810 | PubTator, text mining | PubMed |
| Integrative systems biology identifies PRELP and TAGLN as prognostic biomarkers and immune modulators in colorectal cancer. | Gastroenterol Hepatol Bed Bench | 2025 | 42137131 | PubTator, text mining | PubMed |
| Cross-Regional Transcriptome Data Reveal Transcriptional Abnormalities Associated with Lung Adenocarcinoma. | Rep Biochem Mol Biol | 2025 | 41531656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6876/papers?page=6